← Eichor
Study identifier: NCT05723471 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of a Collaborative Program of Physical Activity of Newly-diagnosed Cancer Patients

Condition: Cancer  ·  Sponsor: University Hospital, Toulouse

PhaseNA
Planned participants350
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

During the last twenty years, the cancer overall incidence has been increasing in europe and developed countries, while diagnostic and therapeutic progress have contributes to a reduction in mortality. Currently, almost 4 million people are treated or followed for cancer in France. The physical, psychological and social after-effects are significant. Adaptated physical activity plays an important role in the rehabilitation process. Overall, meta-analyses carried-out with most frequent cancers demonstrate that physical activity practiced would allow an improvement in quality of life, tolerance to anticancer treatments and survival.

This description comes directly from the study's public registry record.

Talk to the study team

Laura BOGDANOVITCH  ·  0561778437  ·  bogdanovitch.l@chu-toulouse.fr

Always discuss trial participation with your own doctor first.

Locations (2)

CHRU de NancyNancy, France, FranceRecruiting
Stéphanie MOTTONToulouse, France, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05723471